See how top analysts and institutions rate CSX — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Wells Fargo | Upgrade | Equal Weight → Overweight | $40 | 2025-09-25 |
| RBC Capital Mkts | Upgrade | Sector Perform → Outperform | $39 | 2025-09-18 |
| BMO Capital Markets | Downgrade | Outperform → Market Perform | $38 | 2025-08-18 |
| Deutsche Bank | Upgrade | Hold → Buy | $40 | 2025-07-24 |
| TD Cowen | Upgrade | Hold → Buy | $45 | 2025-07-21 |
| BofA Securities | Upgrade | Neutral → Buy | $42 | 2025-07-17 |
| Robert W. Baird | Resumed | Outperform | $38 | 2025-07-01 |
| Susquehanna | Downgrade | Positive → Neutral | $35 | 2025-06-24 |
| Goldman | Downgrade | Buy → Neutral | $35 | 2025-06-02 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 4 | 15 | 7 | 0 | 0 |
| October 2025 | 4 | 15 | 8 | 0 | 0 |
| September 2025 | 4 | 15 | 8 | 0 | 0 |
| August 2025 | 3 | 14 | 10 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for CSX, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
